Results 211 to 220 of about 3,380,123 (349)

The effect of life insurance settlement on insurance market and consumer welfare

, 2020
Jimin Hong
openalex   +2 more sources

Supercritical water deasphalting and desulphurization of heavy fuel oil with comprehensive molecular‐level analysis and techno‐economic analysis

The Canadian Journal of Chemical Engineering, EarlyView.
Supercritical water deasphalting. Abstract The removal of sulphur from heavy fuel oil (HFO) is essential to address environmental concerns and comply with the stringent regulations imposed by the International Maritime Organization (IMO) in 2020. Previously, the acceptable limit for sulphur was 3.5 wt.%, but it was recently changed to 0.5 wt.%.
Biswajit Saha, Sundaramurthy Vedachalam, Nathalie Baquerizo, Ajay K. Dalai, Aiping Chen, Saumitra Saxena, Bassam Dally   +6 more
wiley   +1 more source

Insurance Against Catastrophe: Government Stimulation of Insurance Markets for Catastrophic Events

, 2013
Véronique Bruggeman, Michaël Faure, Tobias Heldt   +2 more
openalex   +1 more source

Optimal dividends for a NatCat insurer in the presence of a climate tipping point

Canadian Journal of Statistics, EarlyView.
Abstract We study optimal dividend strategies for an insurance company facing natural catastrophe claims, anticipating the arrival of a climate tipping point after which the claim intensity and/or the claim size distribution of the underlying risks deteriorates irreversibly.
Hansjörg Albrecher, Pablo Azcue, Nora Muler   +2 more
wiley   +1 more source

Private health insurance in Gulf Cooperation Council countries: A scoping review. [PDF]

Health Policy Open
Reka H, van Kessel R, Mossialos E, Groot W, Pavlova M.   +4 more
europepmc   +1 more source

Insurance Sales Marketing [PDF]

China-USA Business Review, 2018
openaire   +1 more source

"Global Economic Fluctuations and Their Effect on Investment Strategies in the Egyptian Insurance Market"

Aya Saied Hanafy, Rana Mohamed Abdullah
openalex   +1 more source

Measuring the Impact of the Substitution of Innovator Biologics With Biosimilars on Uptake and Costs Among Ontario Public Drug Benefit Recipients

Clinical Pharmacology &Therapeutics, EarlyView.
In Ontario, biologics have historically represented a small proportion of public drug claims but a large proportion of spending. Biosimilars, lower cost alternatives to biologics, offer a potential solution to the rising spending on biologics. From March 2023 to January 2024, the Ontario Ministry of Health required public drug program beneficiaries on ...
Anita Iacono, Martin K. H. Ho, Joanna Yang, Tonya Campbell, William Wynne, Dana Shearer, Lene Andersen, Eric Majer, Shaleesa Ledlie, Mina Tadrous, Tara Gomes   +10 more
wiley   +1 more source

An analysis of cost-saving in the German statutory health insurance system due to the introduction of epoetin alfa biosimilars in Germany. [PDF]

Front Public Health
Raitner I, Müller B, Vijayan A, Zimmermann L, Bramlage P, Ness NH, Müller M.   +6 more
europepmc   +1 more source

Audit quality, the insurance hypothesis and client firm market reaction to auditor lawsuits

, 2001
Carl Pacini, William Hillison
openalex   +1 more source